RESISTIN GENE POLYMORPHISMS: POTENTIAL BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA

DIVYA TANDON

doi:10.22159/ijpps.2024v16i2.49493

Authors

DIVYA TANDON Molecular and AMP, Human Genetics Lab, University of Lucknow, Lucknow, Uttar Pradesh, India https://orcid.org/0000-0002-4924-6509

DOI:

https://doi.org/10.22159/ijpps.2024v16i2.49493

Keywords:

Oral cancer, Resistin, Single nucleotide polymorphisms, RETN, Prognosis

Abstract

Objective: The objective of the work is to study the association between Resistin Gene polymorphisms and susceptibility of Oral Squamous Cell carcinoma.

Methods: In the present study, we scrutinize the connection between four genetic polymorphisms present in RETN gene with the susceptibility, progression, and clinical outcome of OSCC among 200 OSCC patients and 200 healthy controls.

Results: The results of the study reveal that among 260 smokers, the risk of developing OSCC is significantly more among the subjects having history of using betel quid in comparison to those who are not habitual users of betel quid.

Conclusion: The study reveals that patients with OSCC exhibiting G/A heterozygous genotype of RETN rs3219175 polymorphism have lesser risk for developing high-grade tumor compared to the patients with G/G homozygotes in North Indian population.

Downloads

Download data is not yet available.

References

Tandon D, Dewangan J, Srivastava S, Garg VK, Rath SK. miRNA genetic variants: as potential diagnostic biomarkers for oral cancer. Pathol Res Pract. 2018;214(2):281-9. doi: 10.1016/j.prp.2017.10.002, PMID 29103762.

Pindborg J, Reichart P, Smith C, Waal I. Histological typing of cancer and precancer of the oral mucosa, WHO international histological classification of tumors. 2nd ed; 1997.

NIDCR. Oral cancer 5 y survival rate by race, gender, and stage of diagnosis, available. In: https://www.nidcr.nih.gov/research/data-statistics/oral-cancer/survival-rates.

Ajila V, Shetty H, Babu S, Shetty V, Hegde S. Human papilloma virus associated squamous cell carcinoma of the head and neck. J Sex Transm Dis. 2015;2015:791024. doi: 10.1155/2015/791024, PMID 26483987.

Nowak F, Soria JC, Calvo F. Tumour molecular profiling for deciding therapy-the French initiative. Nat Rev Clin Oncol. 2012;9(8):479-86. doi: 10.1038/nrclinonc.2012.42, PMID 22777058.

Das S, Mukherjee S, Choudhury S, Bose A, Roy S. Antioxidant and cytotoxic activities of areca catechu seed extract in swiss albino mice using EAC cell line in different culture medium. Int J Curr Pharm Sci. 2020;12(2):20-7. doi: 10.22159/ijcpr.2020v12i2.37481.

Sumintarti MR, Hajrah Yusuf ASt. Oral hairy leukoplakia manifestations related to CD4 count in HIV/AIDS patients at Dr Wahidin Sudirohusodo Hospital. Int J Appl Pharm. 2019;11(4):57-9. doi: 10.22159/ijap.2019. v11s4.35292.

Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW. Impact of interleukin-18 polymorphisms-607A/C and 137G/C on oral cancer occurrence and clinical progression. PLOS ONE. 2013;8(12):e83572. doi: 10.1371/journal.pone.0083572, PMID 24349532.

Shah S, Mishra G, Kalia K. Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with oral cancer. Oral Cancer. 2018;2(3-4):83-9. doi: 10.1007/s41548-018-0012-1.

Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174(9):5789-95. doi: 10.4049/jimmunol.174.9.5789, PMID 15843582.

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-12. doi: 10.1038/35053000, PMID 11201732.

Shuldiner AR, Yang R, Gong DW. Resistin, obesity, and insulin resistance-the emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001;345(18):1345-6. doi: 10.1056/NEJM200111013451814, PMID 11794158.

John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006;23(11):1511-23. doi: 10.1111/j.1365-2036.2006.02915.x, PMID 16696799.

Danese E, Montagnana M, Minicozzi AM, Bonafini S, Ruzzenente O, Gelati M. The role of resistin in colorectal cancer. Clin Chim Acta. 2012;413(7-8):760-4. doi: 10.1016/j.cca.2012.01.019, PMID 22296675.

Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010;25(2):205-12. doi: 10.1007/s00384-009-0828-6, PMID 19888587.

Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932-9. doi: 10.1161/01.CIR.0000155620.10387.43, PMID 15710760.

Kumar S, Gupta V, Srivastava N, Gupta V, Mishra S, Mishra S. Resistin 420C/G gene polymorphism on circulating resistin, metabolic risk factors and insulin resistance in adult women. Immunol Lett. 2014;162:287-91. doi: 10.1016/j.imlet.2014.07.009, PMID 25088792.

Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001;98(2):502-6. doi: 10.1073/pnas.98.2.502, PMID 11209052.

Vallega KA, Liu NN, Myers JS, Yu K, Sang QXA. Elevated resistin gene expression in African American estrogen and progesterone receptor-negative breast cancer. Plos One. 2016;11(6):e0157741. doi: 10.1371/journal.pone.0157741, PMID 27314854.

Chung CM, Lin TH, Chen JW, Leu HB, Yin WH, Ho HY. Common quantitative trait locus downstream of RETN gene identified by genome‐wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect. Diabetes Metab Res Rev. 2014;30(3):232-40. doi: 10.1002/dmrr.2481, PMID 24123702.

Hu WW, Tang CH, Sun Y, Lu TT, Jiang P, Wu YM. Correlation between resistin gene polymorphism and clinical aspects of lung cancer. Medicine. 2017;96(52):e9485. doi: 10.1097/MD.0000000000009485, PMID 29384942.

Yang WH, Wang SJ, Chang YS, Su CM, Yang SF, Tang CH. Association of resistin gene polymorphisms with oral squamous cell carcinoma progression and development. BioMed Res Int. 2018;2018:9531315. doi: 10.1155/2018/9531315, PMID 30406149.

Vallega KA, Liu NN, Myers JS, Yu K, Sang QXA. Elevated resistin gene expression in African American estrogen and progesterone receptor-negative breast cancer. PLOS ONE. 2016;11(6):e0157741. doi: 10.1371/journal.pone.0157741, PMID 27314854.

Wang L, Tang CH, Lu T, Sun YI, Xu G, Huang CC. Resistin polymorphisms are associated with rheumatoid arthritis susceptibility in Chinese Han subjects. Medicine. 2018;97(12):e0177. doi: 10.1097/MD.0000000000010177, PMID 29561430.

Lin YJ, Ho TJ, Lin TH, Hsu WY, Huang SM, Liao CC. P-coumaric acid regulates exon 12 splicing of the ATP7B gene by modulating hnRNP A1 protein expressions. Biomedicine. 2015;5(2):10. doi: 10.7603/s40681-015-0010-0, PMID 26048696.

Li TC, Li CI, Liao LN, Liu CS, Yang CW, Lin CH. Associations of EDNRA and EDN1 polymorphisms with carotid intima-media thickness through interactions with gender, regular exercise, and obesity in subjects in Taiwan: Taichung Community Health Study (TCHS). Biol Med. 2015;5(2):8. doi: 10.7603/s40681-015-0008-7, PMID 26040574.

Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ, Jeng JH. Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol. 2005;41(8):757-75. doi: 10.1016/j.oraloncology.2005.01.007, PMID 16109353.

Chen YJ, Chang JTC, Liao CT, Wang HM, Yen TC, Chiu CC. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008;99(8):1507-14. doi: 10.1111/j.1349-7006.2008.00863.x, PMID 18754860.

Tsai CH, Tsai HC, Huang HN, Hung CH, Hsu CJ, Fong YC. Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget. 2015;6(1):258-70. doi: 10.18632/oncotarget.2724, PMID 25404641.

Su CM, Huang CY, Tang CH. Characteristics of resistin in rheumatoid arthritis angiogenesis. Biomark Med. 2016;10(6):651-60. doi: 10.2217/bmm.15.125, PMID 26867862.

Su CM, Tang CH, Chi MJ, Lin CY, Fong YC, Liu YC. Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells. Biochem Pharmacol. 2018;154:234-42. doi: 10.1016/j.bcp.2018.05.001, PMID 29730230.

Demiray G, Degirmencioglu S, Ugurlu E, Yaren A. Effects of serum leptin and resistin levels on cancer cachexia in patients with advanced-stage non–small cell lung cancer. Clin Med Insights Oncol. 2017;11:1179554917690144. doi: 10.1177/1179554917690144, PMID 28469508.

Wu CC, Chu HW, Hsu CW, Chang KP, Liu HP. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics. 2015;15(19):3394-404. doi: 10.1002/pmic.201500157, PMID 26205615.

Chang ML, Liang KH, Ku CL, Lo CC, Cheng YT, Hsu CM. Resistin reinforces interferon lambda-3 to eliminate the hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms. Sci Rep. 2016;6:30799. doi: 10.1038/srep30799, PMID 27477870.

Onuma H, Tabara Y, Kawamura R, Tanaka T, Ohashi J, Nishida W. A at single nucleotide polymorphism-358 is required for G at 420 to confer the highest plasma resistin in the general Japanese population. PLOS ONE. 2010;5(3):e9718. doi: 10.1371/journal.pone.0009718, PMID 20300528.

Apalasamy YD, Rampal S, Salim A, Moy FM, Su TT, Majid HA. Polymorphisms of the resistin gene and their association with obesity and resistin levels in Malaysian Malays. Biochem Genet. 2015;53(4-6):120-31. doi: 10.1007/s10528-015-9678-9, PMID 25991560.

Anjum R, Hussain M, Kaur M. Expression of cyclinD1 in varying grades of oral squamous cell carcinoma: an immunohistochemical study. Asian J Pharm Clin Res. 2023;16(6):100-2.

Sathiyamoorthy J, Shyamsundar V, Shanmugam S, Mani JG, Hari R. Immunohistochemical expression of c-kit in oral squamous cell carcinoma patients in south Indian Populations. Asian J Pharm Clin Res. 2018;11(10):247-50. doi: 10.22159/ajpcr.2018.v11i10.27443.